Printer Friendly

Health Outcomes Liaisons' Performance Depends Heavily on Structural Alignment, Says Cutting Edge Information.

Managers first determine HOL activities, then decide which structural alignment will allow them to meet a number of goals

RESEARCH TRIANGLE PARK, N.C. -- When pharmaceutical companies organize their best-performing health outcomes liaison (HOL) teams, decision makers pay careful attention to where the group sits and how it is structured. This initial decision heavily influences the activities the team performs and how well it communicates with groups performing other relevant work. Even some regulations by which the team is governed can change based on placement of the group.

Cutting Edge Information's recent study, "Health Outcomes Liaisons: Managing a Field-Based Team that Speaks the Payer's Language," suggests that for the best results, HOL team managers should determine the ideal set of activities for HOLs and decide which structural alignment will allow the team to meet the greatest number of goals.

"Some large companies have multiple HOL groups based on the therapeutic indications being served," said Jeremy Spivey, senior research analyst at Cutting Edge Information. "Because health outcomes liaisons are typically focused on only a few clinical areas, they can develop strong clinical expertise on certain products."

The study found that in some cases, HOL groups are independent and even sit on different sides of the medical affairs firewall. Such a structure indicates that some HOL groups are positioned to address unsolicited off-label inquiries and some cannot. Most frequently, however, HOL teams' structural positioning is based on the types of payers that they serve, the therapeutic area's specific needs and the therapeutic business unit functions' existing structures.

"Health Outcomes Liaisons: Managing a Field-Based Team that Speaks the Payer's Language" (http://www.cuttingedgeinfo.com/research/market-access/health-outcomes-liaisons/), examines outcomes liaison groups at many of the world's top pharmaceutical companies.

This study contains detailed benchmarks, performance metrics and best practices to build successful health outcomes liaison teams, including:

* Organizational structures

* Budget and staffing benchmarks

* Compensation figures

* Resource allocation metrics

For more information about Health Outcomes Liaisons metrics and market access strategy, contact Elio Evangelista at 919-403-6583.
COPYRIGHT 2012 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2012 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1U5NC
Date:Jul 30, 2012
Words:402
Previous Article:Research and Markets: 2012 Report on the $8 Billion US Parking Lots & Garages Industry.
Next Article:Research and Markets: IT Financial Management in the Cloud Era.
Topics:

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters